Literature DB >> 31060389

Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3.

Lisa V Graves1,2, Stephanie Simone3, McKenna Williams2, Troy Courville4, Sarah N Mattson1,2, Lisa Delano-Wood1,3,5, Mark W Bondi1,3,5, David P Salmon1,6, Jody Corey-Bloom1,6, Dean C Delis1,3, Paul E Gilbert1,2.   

Abstract

The original and second editions of the California Verbal Learning Test (CVLT) used nonparametric and parametric methods, respectively, to assess Total Recognition Discriminability (RD). In a previous study, we found evidence that the nonparametric formula may be more sensitive than the parametric formula to high false positive (FP) rates and provide more accurate assessments of yes/no recognition in neurodegenerative populations prone to high FP rates, including Alzheimer's disease (AD). In the present study, we extended our investigation to examine the utility of CVLT-3 nonparametric and parametric Total RD indices in the assessment and comparison of yes/no recognition in individuals with Huntington's disease (HD) and AD in mild and moderate stages of dementia. Findings suggested that the CVLT-3 nonparametric Total RD index was more sensitive than the parametric index to HD and AD differences in yes/no recognition across mild and moderate stages of dementia. Additionally, group differences on total FP errors were more closely mirrored by group differences on the nonparametric Total RD index. The present results bolster our previous findings and highlight the utility of examining nonparametric (in addition to parametric) Total RD on the CVLT-3 in assessments of yes/no recognition involving clinical populations prone to high FP rates.

Entities:  

Keywords:  Alzheimer’s disease; California Verbal Learning Test-3; Huntington’s disease; nonparametric; total recognition discriminability

Mesh:

Year:  2019        PMID: 31060389      PMCID: PMC6832777          DOI: 10.1080/23279095.2019.1605993

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  9 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia.

Authors:  Dean C Delis; Spencer R Wetter; Mark W Jacobson; Guerry Peavy; Joanne Hamilton; Assawin Gongvatana; Joel H Kramer; Mark W Bondi; Jody Corey-Bloom; David P Salmon
Journal:  J Int Neuropsychol Soc       Date:  2005-10       Impact factor: 2.892

Review 3.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

4.  Depression and stages of Huntington's disease.

Authors:  Jane S Paulsen; Carissa Nehl; Karin Ferneyhough Hoth; Jason E Kanz; Michelle Benjamin; Rachel Conybeare; Bradley McDowell; Beth Turner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

Review 5.  Clinical assessment of memory disorders in amnesia and dementia.

Authors:  N Butters; D C Delis; J A Lucas
Journal:  Annu Rev Psychol       Date:  1995       Impact factor: 24.137

6.  Total recognition discriminability in Huntington's and Alzheimer's disease.

Authors:  Lisa V Graves; Heather M Holden; Lisa Delano-Wood; Mark W Bondi; Steven Paul Woods; Jody Corey-Bloom; David P Salmon; Dean C Delis; Paul E Gilbert
Journal:  J Clin Exp Neuropsychol       Date:  2016-07-21       Impact factor: 2.475

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II.

Authors:  Eric M Fine; Dean C Delis; Spencer R Wetter; Mark W Jacobson; Joanne M Hamilton; Guerry Peavy; Jody Goldstein; Carrie McDonald; Jody Corey-Bloom; Mark W Bondi; David P Salmon
Journal:  J Clin Exp Neuropsychol       Date:  2008-05       Impact factor: 2.475

9.  Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory.

Authors:  N Butters; J Wolfe; M Martone; E Granholm; L S Cermak
Journal:  Neuropsychologia       Date:  1985       Impact factor: 3.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.